Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial()

BACKGROUND: The devastating Coronavirus disease (COVID-19) pandemic is associated with a high prothrombotic state. It is unclear if the coagulation abnormalities occur because of the direct effect of SARS-CoV-2 or indirectly by the cytokine storm and endothelial damage or by a combination of mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramacciotti, Eduardo, Agati, Leandro Barile, Calderaro, Daniela, Volpiani, Giuliano Giova, de Oliveira, Caroline Candida Carvalho, Aguiar, Valéria Cristina Resende, Rodrigues, Elizabeth, Sobreira, Marcone Lima, Joviliano, Edwaldo Edner, Dusilek, Cesar, Itinose, Kenji, Dedivitis, Rogério Aparecido, Cortina, André Sementilli, Sanches, Suzanna Maria Viana, de Moraes, Nara Franzin, Tierno, Paulo Fernando Guimarães Morando Marzocchi, de Oliveira, André Luiz Malavasi Longo, Tachibana, Adriano, Chate, Rodrigo Caruso, Santos, Marcus Vinícius Barbosa, Cavalcante, Bruno Bezerra de Menezes, Moreira, Ricardo Cesar Rocha, Chiann, Chang, Tafur, Alfonso, Spyropoulos, Alex C., Lopes, Renato D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Trial Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409017/
https://www.ncbi.nlm.nih.gov/pubmed/34480880
http://dx.doi.org/10.1016/j.ahj.2021.08.016

Ejemplares similares

Ejemplares similares